Lynx1 Capital Management LP

13F Holdings History for TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Symbol: TCRX on Nasdaq
Investment type: Equity / Voting Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 7.86M shares
Security Ownership: 15%

Shares, Excluding Options vs Price

Value, Excluding Options

Lynx1 Capital Management LP ownership in TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX)

2025-08-14 - Lynx1 Capital Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.86M shares of TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX). This represents 15% percent ownership of the company. In their previous filing dated 2025-02-14, Lynx1 Capital Management LP had reported owning 5.36M shares, indicating an increase of 46.7% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Lynx1 Capital Management LP	15%	+37.3%	$14.1M	7.86M	+2,500,000	+46.7%	$1.80	13G/A	6/30/2025	14 Aug 2025 07:06:26
Lynx1 Capital Management LP	10.9%		$6.8M	5.36M			$1.27	13G/A	12/31/2024	14 Feb 2025 09:00:17

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	3.29%	+1.05%	$11.4M	7.86M	+2,500,000	+46.7%	$1.45	Q2 2025
3/31/2025	2.65%		$7.39M	5.36M			$1.38	Q1 2025
12/31/2024	6.11%	+0.15%	$16.3M	5.36M	+132,747	+2.54%	$3.04	Q4 2024
9/30/2024	9.22%		$26M	5.22M			$4.98	Q3 2024
6/30/2024	11%		$30.6M	5.22M			$5.85	Q2 2024
3/31/2024	10.7%		$41.5M	5.22M			$7.94	Q1 2024
12/31/2023	12%		$30.5M	5.22M			$5.83	Q4 2023
9/30/2023	8.85%		$13.4M	5.22M			$2.56	Q3 2023
6/30/2023	8.56%	+8.56%	$13.1M	5.22M	+5,224,600	NEW	$2.50	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.